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Abstract— The aim of the Physiological Controls Group of 
Obuda University is to investigate pathophysiological 
systems and develop mathematical models in order to create 
automatic control algorithms or model-based treatment 
protocols enhancing personalized healthcare possibilities. 
The presentation deals with the given problem starting with 
a short introduction on the control of diabetes and then 
focuses on tumor control aspects. The latter will be 
presented from the innovative aspect of combining control 
engineering with antiangiogenic targeted molecular therapy, 
rewarded recently by the EU’s European Research Council 
with the highly competitive ERC StG grant. 
Physiological modelling and control represents the 
basic topic of biomedical engineering, the mostly 
developing engineering field nowadays (reflected in the 
recent STEM1 job projections as well). All of the thirteen 
other subdisciplines of biomedical engineering lies on the 
modelling and control aspects. Basically in all these cases 
the two basic challenges to be faced are connected to 
understand the physiological processes by describing them 
in mathematical models, and to find adequate methods to 
identify the required signals from the measured ones. 
Consequently, this approach opens the way to 
personalized healthcare by giving the possibility to 
support medical devices for specific diseases or ease 
everyday life healthcare monitoring (i.e. by smartphone 
applications). As a result, it has a direct connection to the 
nowadays spreading cyber-medical systems’ concept as 
well. 
The Physiological Controls Group2 (PhysCon) of the 
Obuda University was created in 2013 with the aim of 
assembling the physiological and pathophysiological 
research activities at Obuda University, in addtion creating 
a direct connection to medical partners as well. The target 
researches of PhysCon are connected to diabetes (the so-
called artificial pancreas problem), tumor control, 
biostatistical analysis of public health problems and 
control solutions for hemodialysis machines. 
The background of the PhysCon researches lies on the 
robust control engineering approaches developed for 
diabetes. The Artificial Pancreas concept connects 
sensorics (continuous glucose monitors and insulin 
pumps) with the development of a control algorithm to 
treat diabetic patients. The idea was developed for type 1 
diabetes, where the complete insufficiency of the human 
body in producing insulin gives a direct connection to 
drug delivery systems using control engineering 
                                                          
1 STEM – acronym of Science, Technology, Engineering, and 
Mathematics fields. 
2 http://physcon.uni-obuda.hu/?q=en 
applications. A robust control concept was developed at 
PhysCon and tested by in-silico measurements using real 
patient data of the insulin pump centers of the Hungarian 
Artificial Pancreas Working Group. 
In the meantime, the idea was transplanted to cancer 
researches, in particular to the antiangiogenic targeted 
molecular therapy (ATMT) approach. Arising in the last 
decade, the aim of ATMT is to stop the formation of new 
blood vessels and in this way to cease the growth of the 
tumor. However, the corresponding drugs are very 
expensive; moreover, in high dose can cause serious and 
dangerous side effects. The empirically determined 
medical protocols gave us a direct connection to the 
physiological modeling and control idea: reduce and keep 
the tumor in a minimal and safe volume by automated 
control algorithms, and in this way stop tumor growth, 
maintaining it in a minimal, “tamed” form. 
The result of the research could be a personalized 
healthcare approach for drug-delivery in cancer, 
improving the patients’ quality of life (QoL), optimizing 
drug infusion and minimizing treatment costs. Due to the 
heterogeneous nature of the patients, the robust control 
approach is envisaged again. For this, we have to re-
identify the tumor growth model based on the newest 
medical knowledge, to demonstrate the applicability and 
cost-optimality of a quasi-continuous low-dosage therapy 
protocol in medical practice and finally to design adequate 
control algorithm for the problem. 
The above-mentioned goals are the basis of the recently 
rewarded European Research Council’s (ERC) StG grant. 
The ERC grants represent the excellence individual grants 
of the EU, providing attractive and long-term funding for 
researchers who demonstrated scientific excellence. The 
aim of this highly competitive research scheme is to 
promote ground-breaking, high-gain/high-risk research 
ideas in order to boost Europe research competence, but 
also to support principal investigators at the career stage to 
consolidate their research teams. 
The aim of the plenary talk is dual: to give a general 
overview of the interdisciplinary possibilities of the 
physiological control field (focusing specially on cancer 
researches), but also to give a (subjective) example on 
how a research problem could be rewarded as an 
excellence research idea. 
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